Rocky Mountain Environmental Health Association

Members' Notes

Introduction

Biomarkers for EHS, MCS: Treatments

5G from Space

In 2009, a Dr. Dominique Belpomme, who had a long professional career as
France's leading cancer expert, convened a research section under the
Association on Treatment Against Cancer (ARTAC), to research the health
conditions EHS (electromagnetic hypersensitivity) and MCS (multiple chemical
sensitivity) with the goal of finding unique and reliable biomarkers that
identify the health conditions. The results were reviewed in the January
newsletter.

Since then, ARTAC has, based on those biomarkers, developed medical
treatments that have helped many people. A formal scientific paper has not yet
been written, but interim results have been posted on the EHS-MCS website and
Dr. Belpomme has given interviews to several media outlets around Europe. The
following is based on that information.

For a review, ARTAC isolated the following biomarkers -

High Sensitivity C Reactive Protein changes

Vitamins D2, D3 deficiency

Histamine excess

IgE excess

Protein S100B disruption

Nitrotyosine disruption

Heat shock proteins HSP 27 and HSP 70 excess

Anti-O-myelin autoantibody disruption

Hydroxy-melatonin sulfate deficiency

From these biomarkers, ARTAC group developed a standard medical treatment.
Based on the results of the detailed biochemistry and imaging examinations,
each patient was given a treatment that includes administration of -

antagonists for the H1 anti histamine receptor;

antioxidants;

natural plant-derived brain revasculation agents;

high dose vitamins B1, B2, B6;

vitamins D2-D3;

omega 3 oils;

and zinc.

The biomarkers study noted that melatonin was often depleted; but from the
current treatments they said that melatonin supplementation was not "effective
for treating insomnia."

This protocol was reported to be effective enough to cause regression of
the intolerance symptoms in some 60% - 70% of both EHS and MCS cases over some
800 patients.

Especially notable was the fact that the brain blood reperfusion recovered
in some 80 % of the cases after receiving the standard treatment.

This protocol helped many patients improve their quality of life by
reducing intolerance symptoms both clinically and biologically. Some patients
reported returning to an almost normal social life; some even able to hold
down a job.

Some inconsistencies in the treatments led the researchers to distinguish
between symptomatic intolerance and hypersensitivity. The intolerance symptoms
decrease and even disappear in patients under the standard treatment; however
the standard treatment did not not alleviate the hypersensitivity itself.

Dr. Belpomme has also sponsored professional conferences in Brussels in
2015 and 2017 that presented the results of these biomarker studies with the
goal of developing a presentation to the World Health Organization (WHO) to
encourage them to revise their dreadful characterization of EHS and MCS as
"idiopathic" which has discouraged a lot of of acceptance of the health
conditions.

Another common theme in these European studies is a concern for "early
onset Alzheimer's" where a person develops the symptoms of Alzheimer's in
their mid-thirties. Apparently this health condition is becoming common in
Europe. And EHS is considered a pre-cursor to Alzheimer's.

Discussion -

These studies and the treatments based on them support a conceptual model
for EHS and MCS that has been developing for the past fifteen years or so. It
amounts to a weakness or injury to parts of the blood brain barrier that
allows external chemicals (for MCS) or internal body chemicals (for EHS) to
circulate into, and cause injury to the limbic or thalamic sections of the
brain. Those areas are considered the "ancient brain" that developed some two
billion years ago in geologic time when organisms only had to cope with simple
decay products instead of the some 90,000 chemicals in our modern society.

Note that the High Sensitivity C Reactive Protein, Histamine, Protein
S100B, Nitrotyosine, HSP 27 and HSP 70 Heat shock proteins, and Anti-O-myelin
autoantibody biomarkers all amount to the body having a reaction to some kind
of aggravation or injury. The lack of a response to melatonin supplementation
is surprising because melatonin turns out to have many low-level healing
properties beyond its role in supporting the circadian rhythm. Such as
anti-cancer, DNA repair, maintenance of the mitochondria membranes, and
supporting other neuro-regenerative processes. So there is the possibility
that the body is diverting the melatonin to try and fix whatever is causing
the many bio-markers.

Melatonin, in high doses, has been helpful in treating several health
issues. People with MCS have found that a high-dose (some 50 mg) taken after
an exposure helped them recover overnight. An urologist gives breast cancer
patients some 100 mg a night; apparently it helps. Reviews of the melatonin
literature are now saying that everyone, starting in their middle years,
should supplement with melatonin on an ongoing basis for its neuroprotective,
heart, and anti-cancer benefits.

Another concern mentioned in the European medical literature is a form of
Alzheimer's disease called "early onset Alzheimer's." This condition is
considered to be possibly caused by EMR exposure. Since some of the biomarkers
for EHS are the same for Alzheimer's, Dr. Belpomme considers EHS as precursor
for Alzheimer's.

But there is also a genetic condition, a deficiency in a variant of the
APOE gene, that causes Alzheimer's in young people around age 30 and is also
called "early onset Alzheimer's." No mention is made about which condition
they are talking about. Nevertheless, with some 8 - 10 percent of Europeans
having some degree of EHS and projections suggesting as much as 50 percent in
a few years, this is an area of concern.

Dr. Belpomme's work is giving us more and more of a physical basis for
recognizing and developing effective medical support for these health
conditions. He is also trying to improve the political attitudes about EHS and
MCS. He is also raising concerns about the long-term consequences, especially
EHS.

Fri, Feb 23, 2018 08:30 PM

From Cell Phone Task Force -

Dear Friends,

The Santa Fe Alliance for Public Health and Safety filed a lawsuit against
the City of Santa Fe in federal court on January 11. The Alliance includes
doctors, health care practitioners, psychotherapists, artists, teachers, a
Health Department official, a city planner, a world class athlete and others
who have lost jobs and homes to cell towers, or who have patients who have
lost jobs and homes to cell towers. We are asking the court to declare Santa
Fe's 5G ordinance unconstitutional, and to rule that neither the State of New
Mexico nor the U.S. government may prohibit a city from protecting its
citizens. As far as I know, this is the only litigation of its kind in the
United States at the present time.

5G FROM SPACE

One week ago, Elon Musk announced an audacious plan to launch 12,000
low-orbit satellites "to beam an ultrafast, lag-free Internet connection" to
every square inch of the earth. They will contain PHASED ARRAY ANTENNAS and
will operate in the MILLIMETER WAVE SPECTRUM. In other words, 5G FROM SPACE.
The first two test satellites were launched on a Falcon 9 rocket yesterday.
News reports say "The initial satellites in the network are expected to come
online next year."

Each satellite will be the size of a mini-refrigerator and weigh about 400
kg. 4,425 satellites will be at an altitude of about 700 miles and 7,518
satellites will be at an altitude of only 210 miles.

To give you an idea of just how radical of an assault this will be, as of
September 2017 there were a grand total of 1,738 operating satellites in
orbit. About 930 of them were in low orbit (less than 1,000 miles above the
earth). None of them were lower than 400 miles in altitude. Only 208 low orbit
satellites were used for communication. Only 125 (Iridium and Globalstar) were
for cell phone service. None of them provided high speed data. None of them
were phased arrays.

The earth has never experienced anything like this. Even if Musk's Falcon
Heavy rocket could launch 100 of these satellites at a time, which is likely,
that still means 120 rocket launches. If he wants to get them all up there in
a year's time, that's one launch every three days. And there are at least ten
other companies that want to launch thousands of satellites each to do the
same thing. OneWeb plans to launch the first ten of its planned 2,400
satellites in May.

The earth's protective ozone layer is still being depleted, scientists
have just discovered, even though everyone thought the problem was solved by
the Montreal Protocol. With so many rockets blasting holes in the atmosphere
these days, that could be the reason. But nobody is talking about it.

The most current satellite database, kept by the Union of Concerned
Scientists, is here: